NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $55,156 | +0.9% | 541 | 0.0% | 0.01% | +7.7% |
| Q2 2023 | $54,642 | +9.7% | 541 | 0.0% | 0.01% | +8.3% |
| Q1 2023 | $49,817 | -19.9% | 541 | -21.1% | 0.01% | -25.0% |
| Q4 2022 | $62,219 | +17.4% | 686 | 0.0% | 0.02% | +14.3% |
| Q3 2022 | $53,000 | -8.6% | 686 | 0.0% | 0.01% | -6.7% |
| Q2 2022 | $58,000 | -3.3% | 686 | 0.0% | 0.02% | +7.1% |
| Q1 2022 | $60,000 | 0.0% | 686 | +0.1% | 0.01% | 0.0% |
| Q4 2021 | $60,000 | +7.1% | 685 | 0.0% | 0.01% | -6.7% |
| Q3 2021 | $56,000 | -17.6% | 685 | -8.1% | 0.02% | -21.1% |
| Q2 2021 | $68,000 | +17.2% | 745 | +8.9% | 0.02% | +11.8% |
| Q1 2021 | $58,000 | -9.4% | 684 | +0.1% | 0.02% | -19.0% |
| Q4 2020 | $64,000 | +8.5% | 683 | 0.0% | 0.02% | -4.5% |
| Q3 2020 | $59,000 | -1.7% | 683 | 0.0% | 0.02% | -4.3% |
| Q2 2020 | $60,000 | +7.1% | 683 | 0.0% | 0.02% | -8.0% |
| Q1 2020 | $56,000 | -26.3% | 683 | -15.2% | 0.02% | -21.9% |
| Q4 2019 | $76,000 | – | 805 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |